Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Is Whitehawk Therapeutics Whwk Stock Cheap At Current Price Whwk Q4 2025 Earnings Whitehawk Therapeutics Inc. Misses Eps No Revenue 20260406 1 Is Helmerich Hp Stock Near A Bottom Price At 34.72 Down 0.26 20260406 Is Definium Dftx Stock Moving Higher Dftx Q4 2025 Earnings Definium Therapeutics Inc. Posts Minor Eps Miss No Revenue 20260406 1 What Chart Pattern Is Kadant Kai Stock Forming Price At 314.42 Up 6.87 20260408 Should I Buy Nuveen Nmz Stock Today Price At 10.22 Down 1.06 20260406 Is Rithm Rac Stock Testing Resistance Price At 10.42 Up 0.15 20260406 Is Enphase Energy Enph Stock In Consolidation Phase Price At 33.03 Up 3.11 20260408 How Does Currency Impact Ares Mgmt Ares Stock Price At 103.67 Up 3.20 20260413 Is Lb Pharmaceuticals Lbrx Stock Consolidating Price At 25.44 Down 0.97 20260406 What Plutus PLUT management is not saying enough about Drifts Lower 20260508 BEP Brook Renew posts wider than expected Q1 2026 per share loss even as its stock rises modestly FTI TechnipFMC posts 118 percent Q1 2026 EPS beat with shares edging higher after its quarterly earnings release Why Northern NAK earnings beat or miss matters less than you think Q3 2025 Earnings Beat Estimates Why AGNC H Pref AGNCZ might be early to something big Institutional Selling 20260508 Is Mountain MLAAW stock worth initiating exposure MLAAW Latest Quarter Earnings Mountain reports no operating results as it seeks SPAC merger targets The real value proposition of AlTi Global ALTI stock 160 20260508 What Revolve Group RVLV is doing that smarter investors notice Smart Money Active 20260508 STOK Stoke Therapeutics posts wider than expected Q4 2025 loss shares gain slightly despite steep earnings miss Is Helport AI HPAIW the most overlooked stock right now 2478 20260506 How Fulton FULTP is positioning for the next five years Stalls 20260508 Repligen Corporation RGEN Cash Flow Analysis Q4 2025 Better Than Expected